1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with psb 1115 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Müller, CE; Yan, L | 1 |
Bertarelli, DC; Hayallah, AM; Klotz, KN; Meyer, H; Müller, CE; Yan, L | 1 |
2 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and psb 1115
Article | Year |
---|---|
Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Biological Availability; Brain; Cattle; Cell Line; Cricetinae; Drug Stability; Esters; Humans; Hydrolysis; In Vitro Techniques; Liver; Nitrobenzenes; Prodrugs; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Sulfonic Acids; Xanthines | 2004 |
A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Animals; Arylsulfonates; Brain; CHO Cells; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Radioligand Assay; Rats; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Xanthines | 2006 |